Original Research
Published on 13 Aug 2024
Application of hydrogels in cancer immunotherapy: a bibliometric analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1433050
- 1,272 views
Type at least 3 characters
6,679 articles
Articles
Brief Research Report
Published on 13 Aug 2024
First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax)
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1404861
- 2,890 views
Mini Review
Published on 13 Aug 2024
Role of TIM-3 in ovarian cancer: the forsaken cop or a new noble
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1407403
- 1,008 views
Original Research
Published on 13 Aug 2024
Bioinformatics analysis of ERCC family in pan-cancer and ERCC2 in bladder cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1402548
- 1,922 views
Review
Published on 13 Aug 2024
NK cell based immunotherapy against oral squamous cell carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1440764
- 1,700 views
Review
Published on 13 Aug 2024
The role of metabolic reprogramming in immune escape of triple-negative breast cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1424237
- 1,665 views
Original Research
Published on 13 Aug 2024
Identification and validation of Rab GTPases RAB13 as biomarkers for peritoneal metastasis and immune cell infiltration in colorectal cancer patients
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1403008
- 1,303 views
Review
Published on 13 Aug 2024
Ferroptosis: mechanism, immunotherapy and role in ovarian cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1410018
- 1,534 views
Review
Published on 13 Aug 2024
Acute T-cell lymphoblastic leukemia: chimeric antigen receptor technology may offer a new hope
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1410519
- 2,110 views
Original Research
Published on 12 Aug 2024
A bibliometric analysis of drug resistance in immunotherapy for breast cancer: trends, themes, and research focus
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1452303
- 1,708 views
Opinion
Published on 12 Aug 2024
Missed opportunities to increase efficiency of monoclonal antibody development using hybridoma technology and mice as the source animal
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1443726
- 680 views
Original Research
Published on 12 Aug 2024
Current perspectives and trends of CD39-CD73-eAdo/A2aR research in tumor microenvironment: a bibliometric analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1427380
- 2,983 views
Review
Published on 12 Aug 2024
Minimal residual disease detection in lymphoma: methods, procedures and clinical significance
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1430070
- 1,314 views
Review
Published on 09 Aug 2024
Master regulator: p53’s pivotal role in steering NK-cell tumor patrol
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1428653
- 1,858 views
- 1 citation
Systematic Review
Published on 09 Aug 2024
Efficacy and safety of lenvatinib plus pembrolizumab in patients with advanced and recurrent endometrial cancer: a systematic review and meta-analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1404669
- 1,633 views
Original Research
Published on 09 Aug 2024
The relationship between metabolite mediated immune regulatory imbalance and the occurrence of malignant tumors of bone and articular cartilage: a Mendelian randomization study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1433219
- 1,578 views